HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Epithelial ovarian cancers (EOCs) often exhibit morphologic features of embryonic Müllerian duct-derived tissue lineages and colonize peritoneal surfaces that overlie connective and adipose tissues. However, the mechanisms that enable EOC cells to readily adapt to the peritoneal environment are poorly understood. In this study, we show that expression of HOXA9, a Müllerian-patterning gene, is strongly associated with poor outcomes in patients with EOC and in mouse xenograft models of EOC. Whereas HOXA9 promoted EOC growth in vivo, HOXA9 did not stimulate autonomous tumor cell growth in vitro. On the other hand, expression of HOXA9 in EOC cells induced normal peritoneal fibroblasts to express markers of cancer-associated fibroblasts (CAFs) and to stimulate growth of EOC and endothelial cells. Similarly, expression of HOXA9 in EOC cells induced normal adipose- and bone marrow-derived mesenchymal stem cells (MSCs) to acquire features of CAFs. These effects of HOXA9 were due in substantial part to its transcriptional activation of the gene encoding TGF-β2 that acted in a paracrine manner on peritoneal fibroblasts and MSCs to induce CXCL12, IL-6, and VEGF-A expression. These results indicate that HOXA9 expression in EOC cells promotes a microenvironment that is permissive for tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secretion of elevated levels of IL-6 by MSC has been detected upon interaction with malignant cells in several epithelial, hematopoietic and mesenchymal cancers (Table 2) [43, 69, 76, 77, 82, 115–119].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 2×
“Overexpression of Hoxa9 in primary bone marrow cells enhances hematopoietic stem cell regeneration, expands the myeloid progenitor pool, and collaborates with Meis1a to induce AML in mice (52, 53).”
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“Because TGF-β signaling induces EMT in many cell types (31), CAFs in +HOXA9 tumors might also derive from tumor cells.”
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664 · cited 2×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 11×
“A similar difference in FAP induction was also observed (Supplemental Figure 7B).”
InfluentialOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,485 · cited 1×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672 · cited 3×
“However, since progression of EOC is driven by multiple autocrine and paracrine mechanisms (1, 2), we cannot exclude the possibility that HOXA9 also promotes progression of this disease by stimulating other signaling pathways in tumor or host cells.”
Self-citationNovel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467 · cited 3×
“Tothill et al. classified tumors in the AOCS cohort into molecular subtypes by their gene expression signatures (19).”
InfluentialSanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Cited by
Items 101–139 of 139
Shenoy, U. S., Basavarajappa, D. S., Kabekkodu, S. P., & Radhakrishnan, R. A. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01389-x · Cited by 11
“In EOC, HOXA9 facilitates the transcriptional activation of TGF-β2, which in turn triggers the efflux of chemokines such as CXCL12, IL-6, and VEGF-A in peritoneal fibroblasts [73, 81].”
ST8SIA6-AS1 Promotes the Epithelial-to-Mesenchymal Transition and Angiogenesis of Pituitary Adenoma
Li, Z., Zhang, C., Zong, X., Wang, Z., Ren, R., Wang, L., Sun, P., Zhu, C., Guo, M., Guo, G., et al. (2022) · Journal of Oncology · doi:10.1155/2022/7960261 · Cited by 9
Modeling drug resistance in a conjoint normal-tumor setting
Feizabadi, M. S., & Witten, T. M. (2015) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-12-3 · Cited by 9
“Recently reported evidence strongly indicates that the dynamics of tumor cells and the surrounding normal cells are not independent of each other and may be mutually tuned [1-8].”
BackgroundBiological role and clinical implications of homeobox genes in serous epithelial ovarian cancer
Miller, K., Patel, J. N., Ganapathi, M. K., Tait, D. L., & Ganapathi, R. N. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.03.004 · Cited by 8
Li, X.-F., Zhang, H., & Huo, Y. (2022) · Journal of International Medical Research · doi:10.1177/03000605221135864 · Cited by 8
“Additionally, HOXA9 expression in EOC cells has been shown to induce cancer-related fibroblasts and to provide a microenvironment for tumor growth.(11) Another study showed that HOXA9 expression promotes tumor growth and stimulated tumor cells to be attached to peritoneal surfaces via inducing expression of the mesenc…”
BackgroundHOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas
Janmaat, V. T., Liu, H., da Silva, R. A., Wisse, P. H. A., Spaander, M. C. W., ten Hagen, T. L. M., Smits, R., Bruno, M. J., Fuhler, G. M., & Peppelenbosch, M. P. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz038 · Cited by 8
Liu, H. J., Fu, Y., Tang, L. Y., Song, B., Gu, W., Yang, H., Xiao, T., Wang, H., & Chen, P. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101142 · Cited by 7
“For instance, HOXA9 accelerates the progression of ovarian cancer through activation of cancer-associated fibroblasts [17].”
Zhang, Y., Li, K., Wang, W., & Han, J. (2021) · International Journal of Experimental Pathology · doi:10.1111/iep.12401 · Cited by 7
Zhang, Z., Sun, H., Hou, J., Li, L., & Wu, L. (2022) · PubMed · doi:10.14670/hh-18-409 · Cited by 7
Morcellating uterine mesenchymal tumors: The pathologist's view
Pavlakis, K., Messini, I., Yiannou, P., Theofani, G., Chrysanthakis, D., Hilaris, G. E., & Panoskaltsis, T. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13240 · Cited by 7
“Factors such as the action of inflammatory cytokines, growth factors and myofibroblastic stimulation have been implicated in the progression of peritoneal metastasis by carcinoma cells.(26,27) Nevertheless, to our knowledge, studies on the possible interactions between mesenchymal neoplastic cells and the peritoneal e…”
BackgroundAdvances in understanding the molecular mechanisms of borderline ovarian tumors
Chen, S., Huang, L., Liang, M., Xie, Y., Zhou, Z., Ke, Y., & Wu, Z. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1429852 · Cited by 6
“The pro-proliferative effect of HOXA9 is primarily mediated through its transcriptional activation of TGF-β2 gene expression, thus leading to the induction of VEGF-A , CXCL12 , and IL-6 in fibroblasts and mesenchymal stem cells (Ko et al., 2012).”
BackgroundLi, W., Ma, X., Li, X., Zhang, X., Sun, Y., Ning, C., Zhang, Q., Wang, D., & Tang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413431 · Cited by 6
A narrative review of the roles of muscle segment homeobox transcription factor family in cancer
Liu, C., Huang, M., Han, C., Li, H., Wang, J., Huang, Y., Chen, Y., Zhu, J., Fu, G., Yu, H., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-220 · Cited by 6
“Homeodomain proteins can regulate the expression of tumor-derived factors to create a microenvironment that promotes the growth of cancer cells and may also enable cancer cells to escape immune destruction (110).”
Wilczyński, J. R., Wilczyński, M., & Paradowska, E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1201497 · Cited by 5
The role of selected molecular factors in ovarian cancer metastasis
Markowska, A., Sawicki, W., Żurawski, J., Fechner, J., & Markowska, J. (2022) · Ginekologia Polska · doi:10.5603/gp.a2022.0051 · Cited by 4
Revisiting the Use of Normal Saline for Peritoneal Washing in Ovarian Cancer
Akasaka, H., & Naora, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216449 · Cited by 4
Self-citationBansa, A. (2013) · ImmunoGastroenterology · doi:10.7178/ig.26 · Cited by 4
Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer
Cui, W., Bai, X., Bai, Z., Chen, F., Xu, J., Bai, W., & Xi, Y. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05592-3 · Cited by 3
“In ovarian cancer, HOXA9 expression induces normal peritoneal fibroblasts to adopt a cancer-associated fibroblast (CAF) phenotype, stimulating the growth of ovarian cancer and endothelial cells (Ko et al. 2012).”
BackgroundTargeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy
Tang, T. C. Y., Xu, N., & Dolnikov, A. (2020) · Cancer Reports and Reviews · doi:10.15761/crr.1000203 · Cited by 4
“The immune-suppressive TME is enriched with regulatory immune cells such as regulatory T cells (Tregs) [48-55], myeloidderived suppressor cells (MDSCs) [36,39,56,57], tumor-associated macrophages (TAMs) [58-60], and cancer-associated fibroblasts (CAFs) [35,61].”
Background“Friends or foes”: a new perspective of tumour metabolic transcriptional modification
Shi, T., Geng, Q., Wang, Z., Wen, C., Xu, J., Jiao, Y., Diao, W., Gu, J., Deng, T., Xiao, C., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07429-y · Cited by 2
Liu, C., Zhang, Y., Liao, R., Wang, L., Zhou, X., Tan, M., Xu, K., Wang, H., Wang, Q., Zhao, Y., et al. (2025) · Poultry Science · doi:10.1016/j.psj.2025.104995 · Cited by 1
“However, it is noteworthy that HOXA5 and HOXA9 are not only classical genes for hematopoietic stem cells but are also associated with tumors (Ko et al., 2012; Moorthy et al., 2023; Pai et al., 2022; Ye et al., 2023).”
The Prospects of RNAs and Common Significant Pathways in Cancer Therapy and Regenerative Medicine
Gattupalli, M., Dey, P., Poovizhi, S., Patel, R. B., Mishra, D., & Banerjee, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-6008-6_16 · Cited by 2
Haria, D. (2014) · Digital Commons-TMC (Texas Medical Center)
THE ROLE AND MECHANISM OF THE HOMEOBOX GENE HOXA9 IN THE GROWTH OF EPITHELIAL OVARIAN CANCER
Ko, S. Y. (2013) · Digital Commons-TMC (Texas Medical Center)
Self-citationHox Gene Expression in Ovarian Cancer
Kelly, Z., Pandha, H., Madhuri, T. K., Morgan, R., & Michael, A. (2012) · Annals of Oncology · doi:10.1016/s0923-7534(20)32732-0
Khlebus, E., Vuttaradhi, V. K., Welte, T., Khurana, N., Celestino, J., Beird, H. C., Gumbs, C. E., Little, L., Legarreta, A. F., Fellman, B. M., et al. (2023) · doi:10.1158/1541-7786.c.6603389.v1
Using ScRNA-seq to Reveal Lymphocyte Responses to ALV-J in Bone Marrow MicroenvironmentPreprint
Wang, L., Zhou, X., Yang, G., Xie, T., Chen, S., Cui, Z., Liu, A., Wang, Q., Wang, H., & Lan, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2866250/v1
Site-Specific Expression of HOXA Genes in Skin and its Effect on Skin Elasticity
Okuno, R., Hasegawa, S., Hasebe, Y., Kawagishi‐Hotta, M., Yamada, T., Ishii, Y., Arima, M., Iwata, Y., Sugiura, K., & Akamatsu, H. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.04.005
Zheng, H., Ren, L., Chen, G., & Hu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-04245-w
“Comparable data in breast cancer implicate the myeloid zinc finger 1/TGF-β1 axis, whereas HOXA9-driven TGF-β2 transcription governs MSC-to-CAF conversion in ovarian carcinoma [77, 78].”
Lin, S.-C., Liao, Y.-C., Chen, P.-M., Yang, Y.-Y., Wang, Y.-H., Tung, S.-L., Chuang, C.-M., Sung, Y.-W., Jang, T.-H., Chuang, S.-E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26556905
Feng, S., Ding, B., Dai, Z., Yin, H., Ding, Y., Liu, S., Zhang, K., Lin, H., Zhongdang, X. I. A. O., & Shen, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26693826
Givel, A.-M. (2016) · theses.fr (ABES) · doi:10.70675/ecf3f4daze596z4fc6z936bze5e136cb033a
Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways
Yong, C. S. M. (2017) · theses.fr (ABES) · doi:10.70675/6a15c9ffz104az4e9az89fbz7da4882b3e85
Inhibition de facteurs de transcription oncogènes : vers une nouvelle approche thérapeutique
Nhili, R. (2013) · theses.fr (ABES) · doi:10.70675/9e3a03e7za994z4136zac62z4b24a9c08967
Metadata
- Authors
- Ko, S. Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., & Naora, H.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Wake Forest University (US)
- University of Chicago (US)
- Corresponding author
- Naora, Honami
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3603-3617
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461910
- OpenAlex
- W1988224215
- Cited by
- 132
- References
- 62
- Citations by year
- 2025: 10 · 2024: 9 · 2023: 11 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 14 · 2013: 14 · 2012: 2
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RP120390, 4r01ca111882-10)
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01-CA111882, CA141078, CA101826, R01CA101826, R01CA141078, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- HOXA9, epithelial ovarian cancer, cancer-associated fibroblasts, tumor microenvironment, Müllerian ducts, TGF-beta2, mesenchymal stem cells, adipose-derived stem cells, bone marrow-derived stem cells, CXCL12, interleukin-6, VEGF-A, paracrine signaling, tumor growth
- MeSH terms
- Adipose Tissue, Animals, Carcinoma, Cell Differentiation, Cell Division, Epithelial Cells, Female, Fibroblasts, Humans, Mice, Nude, Neoplasm Proteins, Ovarian Neoplasms, Peritoneal Neoplasms, Peritoneum, Prognosis, Tumor Cells, Cultured, Interleukin-6, Gene Expression Regulation, Neoplastic, Culture Media, Conditioned, Homeodomain Proteins, Paracrine Communication, Vascular Endothelial Growth Factor A, Endothelial Cells, Mice, Kaplan-Meier Estimate, Transforming Growth Factor beta2, Chemokine CXCL12, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.